Our team of experts are highly experienced in supporting well-designed crystallization processes and supporting your development by providing deeper insight into the solid-state properties of your drug substance helping you to ensure high product purity and the consistent delivery of the desired crystal modification.
Since the particle size distribution of the product depends upon both the solvent/solute system used and process parameters and equipment properties, crystallization can be employed to engineer particles precisely and with the right properties that ensure the optimum performance of the drug product. By applying our practical know how, theoretical understanding and innovative technical approaches we provide direct support in this area. Integrated into our small scale approach is not only traditional solvent based methodology but we perform also complementary investigations, based on alternative technologies, and thus significantly increase the success rate of providing you with seeds or a manufacturing protocol.
|DSC / MDSC|
|IR (microscopy possibility)|
|Raman (microscopy) LALLS (Malvern 3000, Malvern Mastersizer) |
|TAM (microcalorimetry) Isothermal or Scanning|
|Salt & polymorph screening and selection|
|Crystallisation of “difficult-to-crystallise” compounds|
In addition to the above list, Magle Chemoswed AB performs a broad range of tailor-made investigation services related to material characterization, understanding, troubleshooting and synthesis of gram and kilo quantities.
Thomas has 30 years of experience from working within global pharmaceutical industry. He is expert in solid state characterization of pharmaceutical APIs and formulations and is Solid State Manager within Magle Chemoswed AB since 2019.